Department of Spine Surgery, Wuxi Ninth People's Hospital Affiliated to Soochow University, No. 999 Liangqing Road, Binhu District, Wuxi, Jiangsu, China.
BMC Musculoskelet Disord. 2024 Jul 25;25(1):582. doi: 10.1186/s12891-024-07697-3.
Cervical spondylosis (CS), including myelopathy and radiculopathy, is the most common degenerative cervical spine disease. This study aims to evaluate the clinical outcomes of unilateral biportal endoscopy (UBE) compared to those of conventional anterior cervical decompression and fusion (ACDF) for treating unilateral cervical radiculopathy or coexisting cervical myelopathy induced by unilateral cervical herniated discs.
A prospective, randomized, controlled, noninferiority trial was conducted. The sample consisted of 131 patients who underwent UBE or ACDF was conducted between September 2021 and September 2022. Patients with cervical nerve roots or coexisting spinal cord compression symptoms and imaging-defined unilateral cervical radiculopathy or coexisting cervical myelopathy induced by unilateral cervical herniated discs were randomized into two groups: a UBE group (n = 63) and an ACDF group (n = 68). The operative time, blood loss, length of hospital stay after surgery, and perioperative complications were recorded. Preoperative and postoperative modified Japanese Orthopaedic Association (mJOA) scale scores, visual analog scale (VAS) scores, neck disability index (NDI) scores, and recovery rate (RR) of the mJOA were utilized to evaluate clinical outcomes.
The hospital stay after surgery was significantly shorter in patients treated with UBE than in those treated with ACDF (p < 0.05). There were no significant differences in the neck or arm VAS score, NDI score, mJOA score, or mean RR of the mJOA between the two groups (p < 0.05). Only mild complications were observed in both groups, with no significant difference (p = 0.30).
UBE can significantly relieve pain and disability without severe complications, and most patients are satisfied with this technique. Consequently, this procedure can be used safely and effectively as an alternative to ACDF for treating unilateral cervical radiculopathy or coexisting cervical myelopathy induced by unilateral cervical herniated discs.
This study was registered in the Chinese Clinical Trial Registry on 02/08/2023 ( http://www.chictr.org.cn , #ChiCTR2300074273).
颈椎病(CS)包括脊髓病和神经根病,是最常见的退行性颈椎疾病。本研究旨在评估单侧双通道内镜(UBE)与传统前路颈椎减压融合术(ACDF)治疗单侧颈椎间盘突出症引起的单侧神经根病或共存的脊髓病的临床疗效。
前瞻性、随机、对照、非劣效性试验。纳入 2021 年 9 月至 2022 年 9 月期间接受 UBE 或 ACDF 的 131 例患者。将影像学定义的单侧颈椎神经根或共存脊髓受压症状和单侧颈椎间盘突出症引起的单侧神经根病或共存脊髓病患者随机分为两组:UBE 组(n=63)和 ACDF 组(n=68)。记录手术时间、术中出血量、术后住院时间和围手术期并发症。采用改良日本骨科协会(mJOA)评分、视觉模拟评分(VAS)、颈部残疾指数(NDI)评分和 mJOA 恢复率(RR)评估临床疗效。
UBE 组患者术后住院时间明显短于 ACDF 组(p<0.05)。两组患者颈部或手臂 VAS 评分、NDI 评分、mJOA 评分和 mJOA 平均 RR 差异均无统计学意义(p<0.05)。两组均仅观察到轻度并发症,差异无统计学意义(p=0.30)。
UBE 可显著缓解疼痛和残疾,且无严重并发症,大多数患者对该技术满意。因此,UBE 可作为治疗单侧颈椎间盘突出症引起的单侧神经根病或共存的脊髓病的一种安全有效的替代方法。
本研究于 2023 年 2 月 8 日在中国临床试验注册中心注册(http://www.chictr.org.cn,#ChiCTR2300074273)。